PATENT CLAIM ANALYSIS

Application Number: 16060412
Application Type: Utility
Filing Date: 2018-06
Publication Date: 2018-12
Patent Classification: ["514", "045000"]

Abstract:
The present invention discloses a medicament for the prevention and treatment of tumors, in particular relating to the use of 8-oxo-deoxyguanosine triphosphate (8-oxo-dGTP) in the manufacturing of a medicament for the prevention and treatment of tumors, and a medicament comprising 8-oxo-dGTP for the prevention and treatment of tumors, and falls within the pharmaceutical field. The 8-oxo-dGTP can be used in the manufacturing of a medicament for at least one of the treatment, prevention and control of tumors. The 8-oxo-dGTP has a significant inhibitory effect on tumorigenesis and tumor cell proliferation for many types of tumors, and can serve as a new candidate medicament for the prevention and treatment of tumors. Animal experiments show that the 8-oxo-dGTP is significantly superior to 5-FU in terms of tumor inhibition, therefore has a good industrial availability and great business and social values.

Claim (Index 15):
The medicament for at least one of the treatment, prevention and control of tumors according to  claim 14 , wherein the preparation administered orally is a tablet, a capsule, a flat capsule, a soft capsule, a solution or a suspension; the preparation administered by parenteral injection is a preparation for rapid intravenous injection or continuous infusion; the preparation administered via nasal mucosa is an aerosol, a spray, a mist or a drip agent; the preparation administered transdermally is a gel, an ointment, a sustained release transdermal preparation, a liposomal preparation, a transdermal patch or a transdermal spray; the preparation administered rectally is a suppository or a retention enema; and the depot preparation is a subcutaneously or intramuscularly implanted preparation, or an intramuscularly injected preparation.

Metadata:
- Claim Count in Document: 13.0
- Percentile: 94.0
- Lexical Diversity: 2.11268
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['14424595', '15914479', '15566336', '14431707', '15558620']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7583048704218818
- 35 USC 102 Novelty (BERT): 0.4981369591638125
- Combined Prediction Score: 0.7322880792960749
- Mean Citation Score: 180.300388
- Max Citation Score: 193.63332
- Similarity Product: 123.96837162085536

Labels:
- Claim Label 101: 1
- Claim Label 102: 0
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 0
- Label 101 Adjusted: 0

Dataset: test